BUSINESS MODEL - DIAGNOSTICS COMPANY
Tuesday, February 17, 16:15 - 17:00
Katleen Verleysen | CEO at miDiagnostics
Dr. Katleen Verleysen has been active in the Life Sciences sector for over 20 years and has held various CEO and Board Member positions in the US and Europe. She is currently CEO of miDiagnostics, a MedTech company focused on innovation in cell and gene therapies and is Chair of the BOD of 4Tissue, a biotech company at the forefront of regenerative medicine. She has been voted European CEO of the year in her sector two years in a row (2024 and 2025). Katleen holds a B.Sc. in Chemistry and a Ph.D. in Analytical Chemistry, from the University of Ghent, Belgium. Katleen also received a postdoctoral fellowship from the Medical Center of Duke University (NC, USA).
About miDiagnostics
miDiagnostics’ mission is to provide a comprehensive range of health screening tools that will enable healthcare professionals to make timely therapy decisions and improve patient management in various medical settings.
Accurate diagnostic testing often requires significant processing time, leading to delays in receiving results.
This has driven the demand for fast, high-quality PCR testing that delivers reliable results quickly.
Our proprietary silicon chip and reader require only a small sample volume, perform liquid handling steps completely passively and support an efficient PCR reaction. The results with lab-quality sensitivity and specificity are visualized on a connected device in a user-friendly user interface.
The company is spun out of imec, the world-leading R&D and innovation hub in nanoelectronics and digital technologies, and a research collaboration with Johns Hopkins University, the leading US research and medical center.
| Powered by: BCF Courses BV | Connect with us | Join BioBusiness Winter School | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | Register |
| © Copyright 2021 by BCF Courses |